Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses

Bibliography

• Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med 1995;97:86-90; 3-6
   PubMed Web of Science ®Google Scholar
• Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin 2009;25:1413-20
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Ader HJ, Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-72
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Heine RJ, Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4
   PubMed Web of Science ®Google Scholar
• Karter AJ, Subramanian U, Saha C, Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010;33:733-5
   PubMed Web of Science ®Google Scholar
• Nair KM, Levine MA, Lohfeld LH, "I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risks. Can J Clin Pharmacol 2007;14:e251-9
   PubMedGoogle Scholar
• Hyllested-Winge J, Jensen KH, Rex J. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus. Clin Drug Investig 2010;30:643-74
   PubMed Web of Science ®Google Scholar
• Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20:292-8
   PubMed Web of Science ®Google Scholar
• Peyrot M, Mathews DR, Snoek FJ, An international study of psychological resistance to insulin use among persons with diabetes. Diabetologia 2003;46(Suppl 2):A89
   PubMed Web of Science ®Google Scholar
• Zambanini A, Newson RB, Maisey M, Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239-46
   PubMed Web of Science ®Google Scholar
• Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41
   PubMed Web of Science ®Google Scholar
• Olsen BS, Lilleore SK, Korsholm CN, Novopen Echo for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents and health care professionals. J Diabetes Sci Tech 2010;4:1468-75
   PubMedGoogle Scholar
• Pfutzner J, Hellhammer J, Musholt P, Evaluation of dexterity in insulin-treated patients with type 1 and type 2 diabetes mellitus. J Diabetes Sci Technol 2011;5:158-65
   PubMedGoogle Scholar
• Asakura T, Jensen KH. Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol 2009;3:312-19
   PubMedGoogle Scholar
• Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31
   PubMedGoogle Scholar
• Bastian MD, Wolters NE, Bright DR. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes. Consult Pharm 2011;26:426-9
   PubMedGoogle Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-100
   PubMed Web of Science ®Google Scholar
• Lee WC, Balu S, Cobden D, Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25; discussion 0-1
   PubMed Web of Science ®Google Scholar
• Hornquist JO, Wikby A, Andersson PO, Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990;10:221-30
   PubMed Web of Science ®Google Scholar
• Piscopo MA, Chiesa G, Bonfanti R, Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed 2003;74(Suppl 1):21-5
   PubMedGoogle Scholar
• Coscelli C, Lostia S, Lunetta M, Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7
   PubMed Web of Science ®Google Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
   PubMed Web of Science ®Google Scholar
• Hemmingsen H, Niemeyer M, Hansen MR, A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011; doi: 10.1089/dia.2011.0110. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Pfutzner A, Reimer T, Frokjaer LPF, Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
   PubMed Web of Science ®Google Scholar
• Savas S, Koroglu BK, Koyuncuoglu HR, The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83
   PubMed Web of Science ®Google Scholar
• Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-32
   PubMed Web of Science ®Google Scholar
• Ziegler D, Gries FA, Spuler M, The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabetes Med 1993;10(Suppl 2):82S-6S
   PubMedGoogle Scholar
• Wielandt JO, Niemeyer M, Hansen MR, FlexTouch®: a prefilled insulin pen with a novel injection mechanism with consistent, high accuracy at low (1 IU), medium (40 IU) and high (80 IU) dose settings. J Diabetes Sci Technol 2011;5(10):1195-9
   PubMedGoogle Scholar
• Peyrot M, Rubin RR. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes. Diabetes Technol Ther 2011;13:43-8
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
   PubMed Web of Science ®Google Scholar
• Faurie C, Raymond M. Handedness frequency over more than ten thousand years. Proc Biol Sci 2004;271(Suppl 3):S43-5
   PubMed Web of Science ®Google Scholar
• Buus P, Lilleore SK, Larsen K. Compatibility testing of two types of pen needles with a range of injection pens for diabetes medication. Curr Med Res Opin 2011;27:589-92
   PubMed Web of Science ®Google Scholar
• Niskanen L, Jensen LE, Rastam J, Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-40
   PubMed Web of Science ®Google Scholar
• Wilcoxon F. Individual comparisons by ranking methods. Biom Bull 1945;1:80-3
   Google Scholar
• McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12:153-7
   PubMed Web of Science ®Google Scholar
• Brod M, Kongso JH, Lessard S, Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
   PubMed Web of Science ®Google Scholar
• Lefkowitz M. Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins? J Diabetes Sci Technol 2011;5:136-49
   PubMedGoogle Scholar